Objective To provide evidence‐based recommendations and expert guidance for the
management of antineutrophil cytoplasmic antibody–associated vasculitis (AAV), including …

The objective of this study was to develop European League Against Rheumatism/American
College of Rheumatology classification criteria for polymyalgia rheumatica (PMR). …

Objective To provide evidence‐based recommendations and expert guidance for the
management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) as exemplars of large vessel …

Chronic neuropathic pain, caused by lesions in the peripheral or central nervous system,
comes in many forms. We describe current approaches to the diagnosis and assessment of …

Therapy for polymyalgia rheumatica (PMR) varies widely in clinical practice as international
recommendations for PMR treatment are not currently available. In this paper, we report the …

Cutaneous lupus erythematosus (CLE) is a disfiguring and poorly understood condition
frequently associated with systemic lupus. Previous studies suggest that nonlesional …

This systematic review compares treatment options for patients with giant cell arteritis (GCA)
and evaluates the test accuracy of studies used in diagnosing and monitoring GCA. These …

Objective To provide evidence‐based recommendations and expert guidance for the
management of Kawasaki disease (KD), focusing on clinical scenarios more commonly addressed …

Objective Takayasu’s arteritis (TAK) is a granulomatous large‐vessel vasculitis primarily
affecting the aorta and its proximal branches. TAK can be a difficult disease to diagnose and …

Objective To provide evidence‐based recommendations and expert guidance for the
management of systemic polyarteritis nodosa (PAN). Methods Twenty‐one clinical questions …